Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GEMCITABINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | GEMCITABINE |
| Key Genes/Proteins | DNMT3A, HDAC1, IDH2, LRP1, SIRT1, STAT3 |
| Related Diseases | APOPTOSIS, CANCER, DRUG RESISTANCE, FERROPTOSIS, GLYCOLYSIS |
graph TD
GEMCITABINE["GEMCITABINE"]
GEMCITABINE -->|"targets"| Urothelial_Carcinoma["Urothelial Carcinoma"]
GEMCITABINE -->|"inhibits"| Pancreatic_Tumor_Growth["Pancreatic Tumor Growth"]
GEMCITABINE -->|"synergizes_with"| TUMOR_GROWTH["TUMOR GROWTH"]
GEMCITABINE -->|"activates"| ferroptosis["ferroptosis"]
GEMCITABINE -->|"treats"| PANCREATIC_CANCER["PANCREATIC_CANCER"]
PRMT1_INHIBITION["PRMT1 INHIBITION"] -->|"interacts"| GEMCITABINE
PRMT1["PRMT1"] -->|"targets"| GEMCITABINE
Deoxycytidine_Triphosphate["Deoxycytidine Triphosphate"] -->|"interacts"| GEMCITABINE
IDH2["IDH2"] -->|"activates"| GEMCITABINE
FIBROBLASTS["FIBROBLASTS"] -->|"implicated in"| GEMCITABINE| Target | Relation | Type | Str |
|---|---|---|---|
| Urothelial Carcinoma | targets | disease | 0.85 |
| Pancreatic Tumor Growth | inhibits | process | 0.80 |
| Pancreatic Ductal Adenocarcinoma | treats | disease | 0.80 |
| TUMOR GROWTH | associated_with | phenotype | 0.60 |
| PANCREATIC_CANCER | treats | disease | 0.56 |
| ferroptosis | activates | phenotype | 0.56 |
| APOPTOSIS | associated_with | phenotype | 0.50 |
| DNMT3A | associated_with | gene | 0.50 |
| SIRT1 | associated_with | gene | 0.50 |
| HDAC1 | associated_with | gene | 0.50 |
| FERROPTOSIS | associated_with | phenotype | 0.45 |
| GLYCOLYSIS | associated_with | phenotype | 0.45 |
| CANCER | associated_with | disease | 0.45 |
| LRP1 | associated_with | gene | 0.45 |
| FIBROBLASTS | associated_with | cell_type | 0.45 |
| STAT3 | associated_with | gene | 0.45 |
| PANCREATIC CANCER | associated_with | disease | 0.45 |
| IDH2 | associated_with | gene | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PRMT1 inhibitor | interacts_with | compound | 0.90 |
| PRMT1 INHIBITION | interacts_with | entity | 0.90 |
| PRMT1 | targets | protein | 0.85 |
| Deoxycytidine Triphosphate | interacts_with | compound | 0.85 |
| IDH2 | activates | gene | 0.65 |
| DNMT3A | activates | gene | 0.65 |
| CANCER | associated_with | disease | 0.65 |
| FIBROBLASTS | associated_with | cell_type | 0.55 |
| TUMOR GROWTH | associated_with | phenotype | 0.45 |
| PANCREATIC CANCER | associated_with | disease | 0.45 |
| DRUG RESISTANCE | associated_with | phenotype | 0.45 |
| FERROPTOSIS | associated_with | phenotype | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GEMCITABINE in their description or question text
No additional research found